Why did heart transplant results improve after cyclosporine became available?
Heart transplant results improved significantly after the introduction of cyclosporine because it provided a highly effective method for combating immune rejection of the transplanted organ.1
Following the first human heart transplants in the late 1960s, many surgeons abandoned the procedure due to a lack of adequate therapy to prevent the body from rejecting the new heart. Cyclosporine, a stable cyclic peptide derived from an earth fungus, changed this by specifically targeting and inhibiting the function of T lymphocytes—the white blood cells responsible for attacking foreign tissues.123
By effectively suppressing the immune system without the extreme dangers associated with earlier, less precise agents, cyclosporine allowed for a rapid increase in the success and frequency of heart transplant procedures. Today, it remains a cornerstone of antirejection treatment, enabling many recipients to lead productive lives for years following their surgery.213